| 000 | 01344 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514035358.0 | ||
| 264 | 0 | _c20020905 | |
| 008 | 200209s 0 0 eng d | ||
| 022 | _a0195-6701 | ||
| 024 | 7 |
_a10.1053/jhin.2002.1200 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKarchmer, T B | |
| 245 | 0 | 0 |
_aCost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. _h[electronic resource] |
| 260 |
_bThe Journal of hospital infection _cJun 2002 |
||
| 300 |
_a126-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aCross Infection _xeconomics |
| 650 | 0 | 4 |
_aDisease Outbreaks _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aInfection Control _xeconomics |
| 650 | 0 | 4 |
_aIntensive Care Units, Neonatal _xeconomics |
| 650 | 0 | 4 | _aMethicillin Resistance |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xeconomics |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 |
_aVirginia _xepidemiology |
| 700 | 1 | _aDurbin, L J | |
| 700 | 1 | _aSimonton, B M | |
| 700 | 1 | _aFarr, B M | |
| 773 | 0 |
_tThe Journal of hospital infection _gvol. 51 _gno. 2 _gp. 126-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/jhin.2002.1200 _zAvailable from publisher's website |
| 999 |
_c11985039 _d11985039 |
||